Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Consolidated Net Income: 2020-2024

Historic Consolidated Net Income for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Dec 2024 value amounting to -$140.0 million.

  • Arcutis Biotherapeutics' Consolidated Net Income rose 117.84% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.3 million, marking a year-over-year increase of 77.33%. This contributed to the annual value of -$140.0 million for FY2024, which is 46.58% up from last year.
  • As of FY2024, Arcutis Biotherapeutics' Consolidated Net Income stood at -$140.0 million, which was up 46.58% from -$262.1 million recorded in FY2023.
  • In the past 5 years, Arcutis Biotherapeutics' Consolidated Net Income ranged from a high of -$136.6 million in FY2020 and a low of -$311.5 million during FY2022.
  • For the 3-year period, Arcutis Biotherapeutics' Consolidated Net Income averaged around -$237.9 million, with its median value being -$262.1 million (2023).
  • Its Consolidated Net Income has fluctuated over the past 5 years, first tumbled by 51.02% in 2021, then surged by 46.58% in 2024.
  • Over the past 5 years, Arcutis Biotherapeutics' Consolidated Net Income (Yearly) stood at -$136.6 million in 2020, then slumped by 51.02% to -$206.4 million in 2021, then slumped by 50.93% to -$311.5 million in 2022, then increased by 15.83% to -$262.1 million in 2023, then surged by 46.58% to -$140.0 million in 2024.